Electrochemical redox behavior of noradrenaline in alkaline solution on a glassy carbon electrode has been investigated by in situ UV-vis and CD spectroelectrochemistry by using a long optical path thin-layer cell. The experimental data were processed by using a double logarithmic method of analysis together with nonlinear regression which confirmed that the first step in both the oxidation of noradrenaline and reduction of noradrenochrome is a two-electron irreversible process governed by an EE mechanism. The kinetic parameters of the electrode reactions, i.e., charge transfer coefficient and the number of electrons transferred, α1n1 = 0.11 and α2n2 = 0.23, formal potentials modified with kinetics, E10′ = 0.65 (± 0.01) V and E20′ = 0.72 V and standard rate cnstants, k10 = 7.0(± 0.5) × 10−5 cm s−1 and k20 = (± 0.5) × 10−5 cm s−1,for the first and second steps in the oxidation process of noradrenaline, and similarly, α1n1 = 0.33, α2n2 = 0.58, E10′ = 0.37 (± 0.01) V, E0′ = −0.25 (± 0.01) V and k10≈k20 = 1.06 (± 0.05) × 10−4 cm s−1 for the first and second steps in the reduction process of noradrenochrome were also determined.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: